Company Profiles

driven by the PitchBook Platform

Cardeas Pharma

Description

Developer of inhaled antibiotics to treat hospital-acquired respiratory infections caused by antibiotic-resistant organisms. The company combines formations of antibiotics of two drugs with drug-delivery technology to address resistant gram-negative bacteria.

2010

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$3.5M

Latest Deal Amount

$50.1M

Total Amount Raised

Description

Developer of inhaled antibiotics to treat hospital-acquired respiratory infections caused by antibiotic-resistant organisms. The company combines formations of antibiotics of two drugs with drug-delivery technology to address resistant gram-negative bacteria.

Website:

www.cardeaspharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Other Pharmaceuticals and Biotechnology

Primary Office

2025 First Avenue Suite 1200 Seattle, WA 98121United States +1 (206) 973-1026
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Cardeas Pharma's full profile, request a free trial.

    Cardeas Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Cardeas Pharma Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Cardeas Pharma Investors (8)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Avalon VenturesVenture CapitalMinority000 0000000 0000
    Delphi VenturesVenture CapitalMinority000 0000000 0000
    De Novo VenturesVenture CapitalMinority000 0000000 0000
    Devon Park BioventuresVenture CapitalMinority000 0000000 0000
    H.I.G. BioVenturesVenture CapitalMinority000 0000000 0000
    Avalon Ventures Venture Capital
    Delphi Ventures Venture Capital
    De Novo Ventures Venture Capital
    Devon Park Bioventures Venture Capital
    H.I.G. BioVentures Venture Capital

    Cardeas Pharma Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Bruce Montgomery MDChief Executive Officer, Board Member & Co-Founder
    Melissa Yeager JDCo-Founder & Chief Operating Officer
    Tammy AbuanSenior Director, Clinical Development
    Anthony CaraccioloAdvisor
    David Feigal MDAdvisor
    Bruce Montgomery MD Chief Executive Officer, Board Member & Co-Founder
    Melissa Yeager JD Co-Founder & Chief Operating Officer
    Tammy Abuan Senior Director, Clinical Development
    Anthony Caracciolo Advisor
    David Feigal MD Advisor

    Cardeas Pharma Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Aaron DavidsonH.I.G. BioVenturesCo-Head & Managing Director000 0000
    Bruce Montgomery MDCardeas PharmaChief Executive Officer, Board Member & Co-Founder000 0000
    Court Turner JDAvalon VenturesVenture Partner000 0000
    Kevin KinsellaAvalon VenturesFounder & Managing Director000 0000
    Peter Moldt Ph.DNovoPartner, Novo Ventures000 0000
    Aaron Davidson Co-Head & Managing Director H.I.G. BioVentures
    Bruce Montgomery MD Chief Executive Officer, Board Member & Co-Founder Cardeas Pharma
    Court Turner JD Venture Partner Avalon Ventures
    Kevin Kinsella Founder & Managing Director Avalon Ventures
    Peter Moldt Ph.D Partner, Novo Ventures Novo
    Request full access to PitchBook